
Pipeline
Using its proprietary CAR platform, Leucid Bio has developed a pipeline of assets for the treatment of solid tumours and haematological malignancies.
Using its proprietary CAR platform, Leucid Bio has developed a pipeline of assets for the treatment of solid tumours and haematological malignancies.